These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38030135)

  • 1. Nondual Antiplatelet Therapy Versus Dual Antiplatelet Therapy Before Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis.
    Zhang M; Peng W; Yin S; Zhao Y; Lin Y
    J Cardiovasc Pharmacol; 2024 Apr; 83(4):297-305. PubMed ID: 38030135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet strategy after transcatheter aortic valve replacement: an updated meta-analysis.
    Ma X; Xu Z; Li J; Zhao D; Kong X; Ma J; Ma H; Yun Y; Sun L; Zhang Y; Wei D; Jiao Q; Zou C; Wang Z
    J Cardiovasc Surg (Torino); 2019 Oct; 60(5):624-632. PubMed ID: 31486613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve: The ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) Randomized Clinical Trial.
    Rodés-Cabau J; Masson JB; Welsh RC; Garcia Del Blanco B; Pelletier M; Webb JG; Al-Qoofi F; Généreux P; Maluenda G; Thoenes M; Paradis JM; Chamandi C; Serra V; Dumont E; Côté M
    JACC Cardiovasc Interv; 2017 Jul; 10(13):1357-1365. PubMed ID: 28527771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic therapy in patients after transcatheter aortic valve implantation: a network meta-analysis.
    Turgeon RD; Ellis UM; Barry AR
    Eur Heart J Cardiovasc Pharmacother; 2024 Aug; 10(5):454-464. PubMed ID: 38081213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duration of Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement: Systematic Review and Network Meta-Analysis.
    Kuno T; Yokoyama Y; Briasoulis A; Mori M; Iwagami M; Ando T; Takagi H; Bangalore S
    J Am Heart Assoc; 2021 May; 10(9):e019490. PubMed ID: 33870703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term dual anti-platelet therapy decreases long-term cardiovascular mortality after transcatheter aortic valve replacement.
    Hioki H; Watanabe Y; Kozuma K; Kataoka A; Yashima F; Naganuma T; Araki M; Tada N; Shirai S; Yamanaka F; Mizutani K; Tabata M; Takagi K; Ueno H; Yamamoto M; Hayashida K;
    Heart Vessels; 2021 Feb; 36(2):252-259. PubMed ID: 32880683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of single versus dual antiplatelet therapy after TAVR: A systematic review and meta-analysis.
    Raheja H; Garg A; Goel S; Banerjee K; Hollander G; Shani J; Mick S; White J; Krishnaswamy A; Kapadia S
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):783-791. PubMed ID: 29516608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual versus single antiplatelet therapy in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis.
    Aryal MR; Karmacharya P; Pandit A; Hakim F; Pathak R; Mainali NR; Ukaigwe A; Mahmood M; Badal M; Fortuin FD
    Heart Lung Circ; 2015 Feb; 24(2):185-92. PubMed ID: 25240570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual antiplatelet therapy versus single antiplatelet therapy after transaortic valve replacement: Meta-analysis.
    Alrifai A; Soud M; Kabach A; Jobanputra Y; Masrani A; El Dassouki S; Alraies MC; Fanari Z
    Cardiovasc Revasc Med; 2018 Sep; 19(6S):47-52. PubMed ID: 29580827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procedural outcomes in patients with dual versus single antiplatelet therapy prior to transcatheter aortic valve replacement.
    Seoudy H; Thomann M; Frank J; Lutz M; Puehler T; Lutter G; Müller OJ; Frey N; Saad M; Frank D
    Sci Rep; 2021 Jul; 11(1):15415. PubMed ID: 34326368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: A Meta-Analysis of Randomized Clinical Trials.
    Ahmad Y; Howard JP; Madhavan MV; Leon MB; Makkar RR
    Cardiovasc Revasc Med; 2022 Jan; 34():46-53. PubMed ID: 33514490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Dual-antiplatelet Therapy to Mono-antiplatelet Therapy After Transcatheter Aortic Valve Implantation: Systematic Review and Meta-analysis.
    Gandhi S; Schwalm JD; Velianou JL; Natarajan MK; Farkouh ME
    Can J Cardiol; 2015 Jun; 31(6):775-84. PubMed ID: 25913473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin Alone Versus Dual Antiplatelet Therapy After Transcatheter Aortic Valve Implantation: A Systematic Review and Patient-Level Meta-Analysis.
    Brouwer J; Nijenhuis VJ; Rodés-Cabau J; Stabile E; Barbanti M; Costa G; Mahmoodi BK; Ten Berg JM
    J Am Heart Assoc; 2021 Apr; 10(8):e019604. PubMed ID: 33860685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin Alone Versus Dual Antiplatelet Therapy after Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Lin X; Wang S; Wang L; Guan Y; Huang J
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):271-278. PubMed ID: 33570686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis.
    Verdoia M; Barbieri L; Nardin M; Suryapranata H; De Luca G
    Rev Esp Cardiol (Engl Ed); 2018 Apr; 71(4):257-266. PubMed ID: 28734880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal antiplatelet and antithrombotic regimen post-transcatheter aortic valve replacement.
    Moey MYY; Udani K; Nifong LW; Carabello BA; Morris DL; Shah NN
    Eur J Clin Invest; 2023 Dec; 53(12):e14071. PubMed ID: 37539630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry.
    Sherwood MW; Vemulapalli S; Harrison JK; Dai D; Vora AN; Mack MJ; Holmes DR; Rumsfeld JS; Cohen DJ; Thourani VH; Kirtane A; Peterson ED
    Am Heart J; 2018 Oct; 204():9-16. PubMed ID: 30075326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.
    Kobari Y; Inohara T; Tsuruta H; Yashima F; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
    JACC Cardiovasc Interv; 2023 Jan; 16(1):79-91. PubMed ID: 36599591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.